Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

Many of us are dry eye sufferers. But not everyone is doomed to live with red-eyed irritation forever. We recently discovered ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

I live with lacrimal gland failure, corneal neuralgia, and meibomian gland dysfunction—also known as dry eye. These diseases ...

Recent Publication Reports Durable Results and Patient SatisfactionKNOXVILLE, Tenn., June 3, 2025 /PRNewswire/ -- A new ...

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

Dry eye syndrome, a condition affecting millions of Americans each year, continues to present a frustrating challenge for ...

The eye drops are used to treat symptoms experienced by nearly 4 million Americans following an increasingly common procedure ...

What causes dryness of eyes in the postpartum period? Is it a serious problem? Here's what new mothers need to know.

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.